Albertin A, Casati A, Deni F, Danelli G, Comotti L, Grifoni F, Fanelli G
Department of Anesthesiology, IRCCS H. San Raffaele, University of Milan.
Minerva Anestesiol. 2000 Oct;66(10):691-6.
To compare in a prospective, randomized study the effects on cardiovascular changes after tracheal intubation produced by small doses of either remifentanil or fentanyl.
With Ethical Committee approval, after intravenous midazolam premedication (0.05 mg.kg-1), 30 normotensive, ASA physical status I-II patients, without cardiovascular or respiratory diseases, and with a Mallampati score < 2, were randomly allocated to receive an intravenous bolus of either 3 micrograms.kg-1 fentanyl (n = 15) or 1 microgram.kg-1 remifentanil (n = 15) infused over 60 sec and followed by a 0.15 microgram.kg-1.min-1 continuous intravenous infusion. General anesthesia was then induced with propofol (2 mg.kg-1), followed by atracurium besilate (0.5 mg.kg-1) to facilitate tracheal intubation. Following intubation, the lungs were ventilated mechanically using a 60% nitrous oxide in oxygen mixture with a 1% inspired fraction of sevoflurane. Arterial blood pressure and heart rate were recorded before anesthesia induction (baseline), one minute after induction of anesthesia, immediately after tracheal intubation and every minute for the first five minutes after intubation.
Systolic arterial blood pressure values were significantly higher in the Fentanyl than in the Remifentanil group patients from 2 to 5 min after tracheal intubation (p < 0.01), while no differences were observed between the two groups in either diastolic arterial blood pressure or heart rate values. Four patients in the Remifentanil group (26%) but only one patient in the Fentanyl group (7%) showed systolic blood pressure values < 90 mmHg during the study period (p = not significant); however, the observed decreases in systolic arterial blood pressure values were transient and did not require treatment for any subject.
We conclude that in healthy normotensive patients, the control of cardiovascular responses to tracheal intubation obtained with a 1 microgram.kg-1 loading dose of remifentanil is more effective than that provided by a 3 micrograms.kg-1 bolus of fentanyl, with the advantage of no risks for postoperative respiratory depression.
在一项前瞻性随机研究中,比较小剂量瑞芬太尼或芬太尼对气管插管后心血管变化的影响。
经伦理委员会批准,在静脉注射咪达唑仑进行术前用药(0.05mg·kg-1)后,将30例血压正常、美国麻醉医师协会(ASA)身体状况为I-II级、无心血管或呼吸系统疾病且马兰帕蒂评分<2的患者随机分为两组,分别静脉推注3μg·kg-1芬太尼(n = 15)或1μg·kg-1瑞芬太尼(n = 15),推注时间为60秒,随后以0.15μg·kg-1·min-1的速度持续静脉输注。然后用丙泊酚(2mg·kg-1)诱导全身麻醉,接着用阿曲库铵苯磺酸盐(0.5mg·kg-1)以利于气管插管。插管后,使用含60%氧化亚氮的氧气混合气体和1%吸入浓度的七氟醚进行机械通气。在麻醉诱导前(基线)、麻醉诱导后1分钟、气管插管后立即以及插管后前5分钟每分钟记录动脉血压和心率。
气管插管后2至5分钟,芬太尼组患者的收缩压值显著高于瑞芬太尼组患者(p<0.01),而两组患者的舒张压值或心率值均未观察到差异。在研究期间,瑞芬太尼组有4例患者(26%)出现收缩压值<90mmHg,而芬太尼组仅有1例患者(7%)出现这种情况(p = 无显著性差异);然而,观察到的收缩压值下降是短暂的,且无需对任何受试者进行治疗。
我们得出结论,在健康血压正常的患者中,1μg·kg-1负荷剂量的瑞芬太尼对气管插管心血管反应的控制比3μg·kg-1推注剂量的芬太尼更有效,且具有无术后呼吸抑制风险的优势。